NYSE · Analyst Forecast

Abbott Laboratories (ABT) Stock Forecast & Price Target

$104.76 NYSE: ABT Market Cap $181.44B

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 14, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Abbott Laboratories (ABT), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Abbott Laboratories, analysts forecast revenue rising from $44.67B in 2025 to $65.80B in 2030; the average estimate for 2030 earnings per share is $7.94; with published estimates ranging from $7.62 to $8.12; 25 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$104.76
Consensus targetThe average of the price targets analysts have published.$120.85
Median targetThe middle target, less affected by a single outlier.$120.00
Highest targetThe most optimistic published target.$130.00
Lowest targetThe most pessimistic published target.$112.00
Difference from priceHow far the consensus target sits from today’s price.+15.4%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$44.25B$44.67B$44.76B19
2026$49.25B$49.98B$50.15B20
2027$52.08B$53.64B$54.33B21
2028$53.81B$57.15B$59.72B25
2029$59.52B$61.44B$62.50B12
2030$63.75B$65.80B$66.93B12

Earnings per share forecast

YearLowAverageHighAnalysts
2025$5.14$5.15$5.1619
2026$5.50$5.52$5.5320
2027$5.90$5.93$6.0621
2028$4.06$6.50$7.6125
2029$6.91$7.21$7.3712
2030$7.62$7.94$8.1212

Abbott Laboratories (ABT) forecast — frequently asked questions

What is the analyst price target for Abbott Laboratories?

Analysts covering Abbott Laboratories (ABT) have a consensus price target of $120.85, 15.4% above the current price of $104.76. Published targets range from $112.00 to $130.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Abbott Laboratories's earnings?

The average analyst estimate for Abbott Laboratories (ABT) earnings per share in 2030 is 7.94, with individual estimates between 7.62 and 8.12.

How much revenue is Abbott Laboratories expected to make?

Analysts forecast Abbott Laboratories (ABT) revenue of $65.80B in 2030, based on 12 published estimates.

How many analysts cover ABT?

25 analysts contribute estimates for Abbott Laboratories (ABT). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Devices stocks

ISRG forecastMDT forecastSYK forecastBSX forecastEW forecastRMD forecastDXCM forecastPHG forecastZBH forecastGKOS forecastAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.